跳至主要内容
临床试验/NCT04653623
NCT04653623Unknown不适用

Effect of Tranexamic Acid on Blood Loss After High Tibial Osteotomy

The Catholic University of Korea1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
Hemoglobin level

研究概览

简要总结

This study aims to examine whether tranexamic acid has an meaningful clinical effect on blood loss after high tibial osteotomy. This study design is a double-blind randomized controlled trial. The patients were randomly assigned to intervention or usual care groups. Intervention patients receive tranexamic acid 2g for 10 minutes just before surgery. Primary outcome is hemoglobin level preoperatively, postoperative 1 day, 2 days, 3 days, 2 weeks. Secondary outcome included hematocrit level, hemovac drainage, total blood loss, need for transfusion, deep vein thrombosis, Visual Analog Pain Scale, and wound complication.

详细描述

High tibial osteotomy is proved treatment option for medial compartment osteoarthritis of knee joint. Especially, open wedge high tibial osteotomy might cause moderate amount of bleeding and hematoma formation. Bleeding and hematoma could be a reason of soft tissue infection and wound complications. Tranexamic acid (TXA) is a medication used to treat or prevent excessive blood loss from major trauma, postpartum bleeding, surgery, tooth removal, nosebleeds, and heavy menstruation. The objective of the study is to test whether preoperative tranexamic acid could reduce the postoperative complications due to bleeding.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients for high tibial osteotomy
  • Having medicare insurance
  • Accepted patients

排除标准

  • History of lower extremity infection or neurologic problems
  • Inflammatory arthritis
  • Using thrombins
  • History of treatment for anemia
  • History of thromboembolic event
  • Chronic kidney disease

研究组 & 干预措施

Tranexamic acid before high tibial osteotomy

Experimental

Interventions

  • Procedure/Surgery: High tibial osteotomy
  • Drugs: Tranexamic acid

干预措施: High tibial osteotomy (Procedure)

Tranexamic acid before high tibial osteotomy

Experimental

Interventions

  • Procedure/Surgery: High tibial osteotomy
  • Drugs: Tranexamic acid

干预措施: Tranexamic acid (Drug)

High tibial osteotomy only

Active Comparator

Interventions

  • Procedure/Surgery: High tibial osteotomy

干预措施: High tibial osteotomy (Procedure)

结局指标

主要结局

Hemoglobin level

时间窗: Change from Baseline Hemoglbin level at postoperative 2 weeks

次要结局

  • Number of Participants with Need for transfusion(Postoperative 1, 2, 3 days)
  • Amount of Hemovac drainage(Postoperative 1, 2, 3 days)
  • Total blood loss(Postoperative 1, 2, 3 days)
  • Number of Participants with Need for transfusion Deep vein thrombosis(Until postoperative 2 weeks)
  • Visual Analog Pain Scale [0 - 10](Preoperative & postoperative 1, 2, 3 days, 2 weeks)
  • Hematocrit level(Preoperative & postoperative 1, 2, 3 days, 2 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yong In

Professor

The Catholic University of Korea

研究点 (1)

Loading locations...

相似试验